Simple and safe exclusion of pulmonary embolism using quantitative d-dimer and Wells simplified decision rule

ISRCTN ISRCTN10533382
DOI https://doi.org/10.1186/ISRCTN10533382
Secondary identifying numbers NTR757
Submission date
22/11/2006
Registration date
22/11/2006
Last edited
03/11/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr R J Goekoop
Scientific

Leiden University Medical Hospital
C1-45
P.O. Box 9600
Leiden
2300 RC
Netherlands

Study information

Study designMulticentre, randomised, two-armed clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesExcluding pulmonary embolism (PE) by a clinical decision rule (CDR) indicating PE unlikely, assessed by the Wells simplified decision rule, combined with a normal D-dimer is safe and efficient.
Ethics approval(s)Received from the local medical ethics committee
Health condition(s) or problem(s) studiedPulmonary embolism, clinically suspected
InterventionUpon clinical suspicion, Wells clinical decision rule was performed first and if patients had a score of less than 4.0 points, a D-dimer test followed. Patients with a normal D-dimer concentration had no further tests, pulmonary embolism was considered excluded and patients did not receive anticoagulant treatment.
Intervention typeOther
Primary outcome measurePatients, in whom pulmonary embolism was excluded, were followed up for three months to document the occurrence of venous thromboembolic events or death.
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/03/2002
Completion date01/06/2004

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants879
Key inclusion criteriaOutpatients with clinically suspected PE
Key exclusion criteria1. Anticoagulant therapy for more than 24 hours
2. Aged under 18 years
3. Pregnancy
4. Allergy to contrast media
5. Expected survival less than three months
6. Venous thrombo-embolism in the previous six months
7. Refusal or inability to consent
Date of first enrolment01/03/2002
Date of final enrolment01/06/2004

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Leiden University Medical Hospital
Leiden
2300 RC
Netherlands

Sponsor information

Leiden University Medical Centre (LUMC) (The Netherlands)
Hospital/treatment centre

Department of General Internal Medicine
P.O. Box 9600
Leiden
2300 RC
Netherlands

Website http://www.lumc.nl/english/start_english.html
ROR logo "ROR" https://ror.org/027bh9e22

Funders

Funder type

Hospital/treatment centre

Unrestricted grants from the participating hospitals

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/01/2007 Yes No